Navigation Links
Xanodyne Pharmaceuticals Appoints New Chief Operating Officer
Date:5/17/2011

NEWPORT, Ky. and MOUNT ARLINGTON, N.J., May 17, 2011 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., is pleased to announce that Fabrice Egros has been appointed to the position of Chief Operating Officer reporting to Natasha Giordano, President and Chief Executive Officer.

Fabrice Egros has more than 20 years of experience in the pharmaceutical industry and prior to Xanodyne served in various senior positions in UCB Pharmaceuticals (Belgium, US and Japan).  His depth of experience includes senior leadership positions in general management, corporate business development, clinical development & regulatory as well as marketing and sales in Europe, Asia and the US at major pharmaceutical companies including Sanofi-Aventis and Parke-Davis.

Mr. Egros said, "I look forward to working with Natasha and the management team in continuing to drive toward our vision of being a leader in the pain management category.  Xanodyne has a proven track record of bringing innovative products to the market and developing strategic partnerships where desired, as well as the people, resources and strategy to focus Xanodyne on high growth opportunities within the pain franchise."  

Ms. Giordano said, "I am very pleased to welcome Fabrice to our management team.  His global knowledge of the industry, deep experience in corporate development and his strong leadership will help us achieve our strategic goals and commercial success in pain management."

About Xanodyne Pharmaceuticals, Inc.

Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management. Xanodyne markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins.  Additionally, we are advancing a late stage pipeline of product candidates targeted at significant potential markets in Xanodyne's focus area.  For more information, vis
'/>"/>

SOURCE Xanodyne Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market
2. Xanodyne Announces Planned President & CEO Succession
3. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
4. Xanodyne Announces Renewed Focus on Pain Management Market
5. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
6. Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio
7. Access Pharmaceuticals Provides Update on MuGard Commercial Activities
8. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
9. Amylin Pharmaceuticals Files Suit Against Eli Lilly
10. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
11. Reportlinker Adds Pharmaceuticals Reports Bundle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Silver Creek Pharmaceuticals, Inc. announced today ... grant from the National Institute of Health (NIH). ... Francisco based biotechnology company that discovers and ... by disease. This award will be used to advance ... following a heart attack. Silver Creek,s Smart ...
(Date:5/5/2015)... , May 5, 2015 GW Pharmaceuticals ... "Company"), a biopharmaceutical company focused on discovering, developing ... product platform, announced today the closing of the ... by GW of 1,600,000 American Depositary Shares (ADSs) ... gross proceeds of approximately $179.2 million (before deducting ...
(Date:5/5/2015)... May 5, 2015  IBM Watson Health (NYSE: IBM ... and Mayo Clinic to advance patient health ... Health Records (EHRs). As Watson,s capabilities are ... and thorough analysis of the medical factors that could impact ... more than 350 customers – some of the largest and ...
Breaking Medicine Technology:Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 2IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 3IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 4
... 23 Reportlinker.com announces that a new market research ... Eli Lilly & Co.: PharmaVitae Profile ... analysis examines the historical and forecast performance for Eli ... global company strategy, portfolio and pipeline analysis and assessment ...
... Sept. 23 As technologies for fat removal become ... not only reshaping the body but also recycling the ... to the most recent statistics from the American Society ... are among the two most popular invasive and non-invasive ...
Cached Medicine Technology:Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 2Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 3Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 4Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 5Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 6Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 7The New Face of Body Contouring 2
(Date:5/5/2015)... 05, 2015 With the FCPX LUT: Monochromatic ... and easily add washed color grades to footage. A LUT ... modifying an image. The LUT changes every pixel's color to ... with 90 washed CUBE LUT files. , This plugin was ... give any footage a washed look. , CUBE LUT ...
(Date:5/5/2015)... Ras Al Khaimah, UAE (PRWEB) May 05, 2015 ... Grace Century , FZ LLC has announced that ... ’, monthly enrollment for Store-A-Tooth™ increased once again--in April, ... the company’s 40th month of increased record volume and ... , Marketing for Provia’s dental stem cell biobank is ...
(Date:5/5/2015)... Beverly Hills Cosmetic Dentist, Arthur Glosman released a ... be sold at the offices of Arthur Glosman DDS, 450 ... through an online store . “I wanted to be ... dental care and beauty with a luxurious collection of products ... Glosman. , Dr. Glosman’s Advanced Dental Health + Beauty™ ...
(Date:5/5/2015)... 05, 2015 NCPDP announced today that ... The program establishes a three-year commitment of strategic support ... 10 Elite Partners. “AmerisourceBergen has supported our multi-stakeholder forum ... NCPDP, “and this is a wonderful continuation and expansion ... can trace AmerisourceBergen back to our very first Board ...
(Date:5/5/2015)... AxoGen, Inc. (NASDAQ: AXGN), a leading ... nerve repair market, reported record revenue of $4.95 million ... to $3.14 million in the year-ago first quarter. ... of nerve repair products - Avance® Nerve Graft, ... our solid sales execution delivered another record quarter with ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4
... Starting to Embrace Use of Targeted Agents Despite ... Decision Resources WALTHAM, Mass., April 28 Decision ... advisory firms focusing on pharmaceutical and healthcare issues, ... Roche/Chugai,s Xeloda, Indian brand/generics (capecitabine) will dominate the ...
... 28 First quarter federal reports show Google ... the federal economic stimulus act, contradicting the Internet ... its effort was "100 percent false."Google,s report shows ... the period including on "online health-related initiatives; issues ...
... EAST LANSING, Mich., April 28 Richard E. Smith, ... was installed as the 144th president of the Michigan ... the annual MSMS House of Delegates meeting in Grand ... Smith, the first African American to serve as MSMS ...
... Institutet have shown that rapid diagnostic tests (RDT) for ... low and mid-income countries in the fight against the ... blood test and, according to the results, helps to ... right treatment at no extra cost for the healthcare ...
... Medical International Technology Inc. (MDLH. PK) ( http://www.mitcanada.ca ... announce that it has received a US$ 200,000 private ... from our partners is an important step towards the ... MIT,s technology and products. , This joint ...
... promoting a painless new method for detecting diabetes, ... at the American Association of Clinical Endocrinologists (AACE) ... Texas.(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b ... diabetes, doctors examined the saliva of 40 different ...
Cached Medicine News:Health News:Sanofi-Aventis' and Roche/Chugai's Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013 2Health News:Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giant's Denials 2Health News:Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giant's Denials 3Health News:Richard E. Smith, M.D., Installed as President of Michigan State Medical Society 2Health News:Richard E. Smith, M.D., Installed as President of Michigan State Medical Society 3Health News:Simple blood test proves powerful ally in the fight against malaria 2Health News:MIT is pleased to announce that it has received a US$ 200,000 private placement from its future Chinese partners 2Health News:Detecting Diabetes Without a Needle: The Spit Factor 2
... of temporary sensing and pacing leads. Our ... temporary pacing leads and improved upon the ... and less traumatic to heart tissue. , ... Lead is designed for temporary atrial and ...
Carbo-Seal Valsalva AAP is the first valved graft to replicate the natural Sinus of Valsalva, encouraging the natural formation of systolic vortices....
... primary indication for this technique is ... organic. Indications for tricuspid repair are ... insufficiency as diagnosed by angiography and ... treatment. In patients with an irreversible ...
Current annuloplasty rings and bands are designed for symmetric dilatation. The IMR ETlogix ring is the first asymmetric ring designed to treat asymmetric dilatation....
Medicine Products: